CBD for Dogs

CBD for Dogs: What Every Pet Owner Needs to Know in 2025

ZenWeedGuide Editorial Team  |  May 11, 2026

By the ZenWeedGuide Editorial Team  |  Updated 2025  |  8 min read

Background: Why CBD for Dogs Is More Than a Trend

The intersection of cannabis science and veterinary medicine has produced one of the most talked-about developments in pet health over the past decade: cannabidiol (CBD) for dogs. As cannabis legalization has swept across the United States and public understanding of the endocannabinoid system has deepened, millions of pet owners have begun asking the same question — can what helps me also help my dog?

The answer, according to emerging science, is a nuanced "possibly." Dogs, like all mammals, possess a fully functioning endocannabinoid system (ECS) — a network of receptors (CB1 and CB2) distributed throughout the brain, nervous system, immune system, and organs. This biological infrastructure responds to endogenous cannabinoids produced by the body, and researchers now know it also responds to plant-derived cannabinoids like CBD. Because dogs have a particularly high concentration of CB1 receptors in the cerebellum — higher than most other mammals — they are both potentially more responsive to cannabinoid therapies and more sensitive to the adverse effects of THC.

The 2018 Farm Bill was a turning point. By federally legalizing hemp-derived CBD (defined as cannabis containing less than 0.3% THC), the legislation opened the door for a legal pet CBD industry almost overnight. Entrepreneurs, wellness brands, and even veterinary researchers rushed to fill the space. Today, CBD pet products — from oil tinctures and soft chews to infused dog biscuits — line the shelves of pet stores, dispensaries, and online retailers across the country.

But the regulatory landscape remains complicated. The FDA has not approved any CBD product for veterinary use, leaving consumers to navigate a market with inconsistent labeling, variable potency, and limited quality oversight. Understanding the science, the regulations, and the real-world evidence is essential for any pet owner considering CBD for their dog. Learn more in our cannabis explainers section.

Key Developments: A Timeline of CBD and Canine Health Research

The story of CBD for dogs has unfolded quickly over the past decade. The following table highlights the most significant milestones in research, regulation, and market development.

Impact on Consumers: How CBD for Dogs Affects Everyday Pet Owners

For the typical dog owner, the CBD landscape presents both exciting possibilities and real challenges. The promise of a natural, low-side-effect option for managing a beloved pet's pain, anxiety, or seizures is compelling — especially when conventional medications carry significant side effect profiles or fail to fully address the problem. Anti-inflammatory drugs (NSAIDs) commonly prescribed for canine arthritis, for example, carry risks of gastrointestinal damage and liver problems with long-term use. Phenobarbital, used for seizure management, requires regular blood monitoring and can cause sedation and liver toxicity. Against this backdrop, CBD's relatively mild side effect profile — primarily mild sedation and, at high doses, temporary elevation of liver enzymes — looks attractive to many owners.

Survey data supports widespread consumer interest. A 2023 survey published in the Journal of the American Holistic Veterinary Medical Association found that 79% of pet owners who had given CBD to their dogs reported improvements in the targeted condition, most commonly pain, anxiety, and skin issues. However, consumer education remains a critical gap. Many owners do not know how to evaluate product quality, interpret a certificate of analysis (COA), or identify appropriate dosing ranges.

Quality control is arguably the biggest consumer protection issue in the pet CBD space. A 2020 study published in PLOS ONE tested 29 commercially available CBD pet products and found that only 45% contained CBD within 20% of the labeled amount. Several products contained detectable levels of THC — a serious concern given that THC is toxic to dogs. Pet owners should always look for:

• Third-party COA: An independent lab certificate of analysis confirming CBD content and THC levels below detectable thresholds.
• Hemp-specific sourcing: Products made from industrial hemp, not marijuana, to ensure legal THC limits.
• Veterinary formulation: Products designed specifically for animals, with appropriate carrier oils (avoid products using essential oils toxic to dogs).
• Clear dosing instructions: Products that provide weight-based dosing guidelines.

It's also important for pet owners to understand the legal dimension. While hemp-derived CBD is federally legal, individual state cannabis laws vary significantly, and some states impose additional restrictions on CBD pet products. Always verify local regulations before purchasing.

Industry Perspective: A Market Growing Faster Than Its Regulations

The pet CBD market is one of the fastest-growing segments of the broader cannabinoid industry. Market research firm Grand View Research valued the global CBD pet market at over $400 million in 2024 and projects it will reach nearly $1.7 billion by 2030, growing at a compound annual growth rate (CAGR) of approximately 30%. Dogs represent the largest share of that market, accounting for roughly 65% of pet CBD sales.

Major players in the space include brands like ElleVet Sciences, Honest Paws, cbdMD, and Charlotte's Web, many of which have invested in third-party research partnerships and publish detailed COAs. The market's rapid maturation has also attracted investment from mainstream pet food companies, suggesting that institutional capital views pet CBD as a durable, not speculative, category.

From a regulatory standpoint, the FDA's stance has been the industry's most significant headwind. The agency has issued warning letters to companies making unsubstantiated health claims but has stopped short of developing a formal approval pathway for hemp-derived animal products. In 2023, the FDA acknowledged the growing demand for such a framework and signaled that congressional action — rather than agency rulemaking alone — may be required. Industry groups, including the US Hemp Roundtable and the Pet Industry Joint Advisory Council (PIJAC), have lobbied actively for clearer federal guidance. Until that framework exists, the market will continue operating in a regulatory gray zone that challenges both responsible companies and concerned consumers.

What Experts Say: Veterinarians, Researchers, and Advocacy Groups Weigh In

The veterinary and cannabis policy communities have increasingly engaged with the question of CBD for dogs, though positions remain nuanced and cautious.

"The evidence we have is promising, but we need large, well-controlled clinical trials before we can make definitive recommendations. In the meantime, pet owners should work with their veterinarian and choose only high-quality, third-party tested products."

The American Veterinary Medical Association (AVMA) has taken a measured but increasingly open stance. While the organization stops short of formally recommending CBD, it has called for additional research funding and updated its guidance to encourage open client-veterinarian communication about cannabis products. The AVMA has also warned against the use of any THC-containing products in animals.

Researchers…